PortfoliosLab logoPortfoliosLab logo
NAGE vs. TBRG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NAGE vs. TBRG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Niagen Bioscience, Inc (NAGE) and TruBridge Inc (TBRG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NAGE achieves a -45.44% return, which is significantly lower than TBRG's 18.89% return. Over the past 10 years, NAGE has outperformed TBRG with an annualized return of -0.96%, while TBRG has yielded a comparatively lower -3.55% annualized return.


NAGE

1D
2.36%
1M
0.58%
6M
-45.70%
YTD
-45.44%
1Y
-69.29%
3Y*
28.91%
5Y*
-17.66%
10Y*
-0.96%

TBRG

1D
0.00%
1M
0.46%
6M
20.15%
YTD
18.89%
1Y
18.95%
3Y*
2.33%
5Y*
-3.79%
10Y*
-3.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NAGE vs. TBRG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NAGE
Niagen Bioscience, Inc
-45.44%19.89%270.98%-14.88%-55.08%-22.08%11.37%25.66%-41.67%77.64%
TBRG
TruBridge Inc
18.89%11.92%76.07%-58.85%-7.10%9.17%2.84%6.78%-15.30%31.11%

Correlation

The correlation between NAGE and TBRG is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (10Y)
Calculated over the trailing 10-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Jul 15, 2008

0.10

The correlation between NAGE and TBRG shifts across timeframes, from 0.07 (3 years) to 0.18 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NAGE:

$276.37M

TBRG:

$393.58M

EPS

NAGE:

$0.22

TBRG:

$0.30

PE Ratio

NAGE:

15.87

TBRG:

87.27

PS Ratio

NAGE:

2.27

TBRG:

1.10

PB Ratio

NAGE:

3.56

TBRG:

2.14

Total Revenue (TTM)

NAGE:

$130.42M

TBRG:

$346.84M

Gross Profit (TTM)

NAGE:

$83.83M

TBRG:

$183.86M

EBITDA (TTM)

NAGE:

$13.37M

TBRG:

$57.80M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NAGE vs. TBRG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NAGE
NAGE Risk / Return Rank: 33
Overall Rank
NAGE Sharpe Ratio Rank: 11
Sharpe Ratio Rank
NAGE Sortino Ratio Rank: 11
Sortino Ratio Rank
NAGE Omega Ratio Rank: 22
Omega Ratio Rank
NAGE Calmar Ratio Rank: 44
Calmar Ratio Rank
NAGE Martin Ratio Rank: 88
Martin Ratio Rank

TBRG

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NAGE vs. TBRG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Niagen Bioscience, Inc (NAGE) and TruBridge Inc (TBRG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NAGETBRGDifference
Sharpe ratioReturn per unit of total volatility

-1.75

Sortino ratioReturn per unit of downside risk

-3.37

Omega ratioGain probability vs. loss probability

0.70

1.12

-0.42

Calmar ratioReturn relative to maximum drawdown

-0.96

0.35

-1.31

Martin ratioReturn relative to average drawdown

-1.43

1.00

-2.43

NAGE vs. TBRG - Sharpe Ratio Comparison

The current NAGE Sharpe Ratio is -1.40, which is lower than the TBRG Sharpe Ratio of 0.35. The chart below compares the historical Sharpe Ratios of NAGE and TBRG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NAGE vs. TBRG - Drawdown Comparison

The maximum NAGE drawdown since its inception was -97.00%, which is greater than TBRG's maximum drawdown of -86.87%. Use the drawdown chart below to compare losses from any high point for NAGE and TBRG.


Loading charts...

Drawdown Indicators


NAGETBRGDifference

Max Drawdown

Largest peak-to-trough decline

-97.00%

-86.87%

-10.13%

Max Drawdown (1Y)

Largest decline over 1 year

-72.26%

-40.65%

-31.61%

Max Drawdown (3Y)

Largest decline over 3 years

-77.86%

-71.31%

-6.55%

Max Drawdown (5Y)

Largest decline over 5 years

-88.57%

-79.46%

-9.11%

Max Drawdown (10Y)

Largest decline over 10 years

-93.65%

-79.61%

-14.04%

Current Drawdown

Current decline from peak

-81.48%

-54.97%

-26.51%

Average Drawdown

Average peak-to-trough decline

-75.74%

-35.89%

-39.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

48.33%

14.38%

+33.95%

Volatility

NAGE vs. TBRG - Volatility Comparison

Niagen Bioscience, Inc (NAGE) has a higher volatility of 12.91% compared to TruBridge Inc (TBRG) at 0.41%. This indicates that NAGE's price experiences larger fluctuations and is considered to be riskier than TBRG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NAGETBRGDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.91%

0.41%

+12.50%

Volatility (6M)

Calculated over the trailing 6-month period

35.31%

32.77%

+2.54%

Volatility (1Y)

Calculated over the trailing 1-year period

49.68%

41.28%

+8.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

76.83%

42.75%

+34.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.46%

41.99%

+36.47%

Dividends

NAGE vs. TBRG - Dividend Comparison

Neither NAGE nor TBRG has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
NAGE
Niagen Bioscience, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TBRG
TruBridge Inc
0.00%0.00%0.00%0.00%0.00%0.00%1.12%1.52%1.59%2.83%7.88%5.15%

Financials

NAGE vs. TBRG - Financials Comparison

This section allows you to compare key financial metrics between Niagen Bioscience, Inc and TruBridge Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00M40.00M60.00M80.00M100.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
31.47M
87.79M
(NAGE) Total Revenue
(TBRG) Total Revenue
Values in USD except per share items

NAGE vs. TBRG - Profitability Comparison

The chart below illustrates the profitability comparison between Niagen Bioscience, Inc and TruBridge Inc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

45.0%50.0%55.0%60.0%65.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
63.5%
54.3%
Portfolio components
NAGE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Niagen Bioscience, Inc reported a gross profit of 19.98M and revenue of 31.47M. Therefore, the gross margin over that period was 63.5%.

TBRG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, TruBridge Inc reported a gross profit of 47.65M and revenue of 87.79M. Therefore, the gross margin over that period was 54.3%.

NAGE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Niagen Bioscience, Inc reported an operating income of 1.58M and revenue of 31.47M, resulting in an operating margin of 5.0%.

TBRG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, TruBridge Inc reported an operating income of 4.98M and revenue of 87.79M, resulting in an operating margin of 5.7%.

NAGE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Niagen Bioscience, Inc reported a net income of 6.32M and revenue of 31.47M, resulting in a net margin of 20.1%.

TBRG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, TruBridge Inc reported a net income of -4.29M and revenue of 87.79M, resulting in a net margin of -4.9%.


Frequently Asked Questions


NAGE and TBRG have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NAGE has higher volatility (12.91%) compared to TBRG (0.41%). In terms of maximum drawdown, NAGE dropped -97.00% vs TBRG's -86.87%.

TBRG currently has the higher Sharpe Ratio (0.35 vs -1.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NAGE and TBRG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer